Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database
- PMID: 19816616
- PMCID: PMC2756639
- DOI: 10.1111/j.1477-2574.2009.00095.x
Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database
Abstract
Background: For the past two decades multiple series have documented that liver resection has become safer. The purpose of this study was to determine the current status of hepatic resection in the USA by analysing the multi-institutional experience within the National Surgical Quality Improvement Program (NSQIP) dataset.
Methods: Of the 363,897 cases in the 2005-2007 NSQIP Participant Use File, 2313 elective open hepatectomy cases were identified (1344 partial, 230 left, 510 right and 229 extended hepatectomies). A total of 57 perioperative risk factors and 28 postoperative complications were compared. To determine the applicability of NSQIP general risk models to hepatic surgery, the prognostic value of standard multivariate analysis was compared with the NSQIP general surgery aggregate risk indices (expected probability of morbidity [morbprob], expected probability of mortality [mortprob]).
Results: The median age of patients listed in the database was 60 years; sex distributions were equivalent; 78% were White; 65% of patients had an ASA score of 3 or 4, and the most prevalent co-morbidity was hypertension (46%). A total of 41% of patients had disseminated cancer, 19% of whom had received chemotherapy within 30 days of surgery. The overall 30-day mortality rate was 2.5% (57/2313) and the 30-day major morbidity rate was 19.6% (453/2313). Multivariate analysis identified nine risk factors associated with major morbidity and two risk factors associated with mortality. In contrast, the morbprob and mortprob statistics did not predict outcomes accurately. For those patients who developed major morbidity, the median length of stay was longer (10 vs. 6 days; P = 0.001) and the mortality rate was higher (11.3% vs. 0.3%; P = 0.001).
Conclusions: Analysis of the NSQIP experience with hepatectomy indicates that the current mortality and major morbidity rate benchmarks are 2.5% and 19.6%, respectively. Poor outcomes were associated with nutritional status, liver function and the extent of hepatectomy. The NSQIP general surgery morbprob and mortprob values were relatively poor predictors of post-hepatectomy observed morbidity, indicating the need for specialty-specific NSQIP modelling.
Keywords: liver resection; morbidity; mortality; surgical quality.
Similar articles
-
The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.Surgery. 2016 May;159(5):1308-15. doi: 10.1016/j.surg.2015.11.020. Epub 2015 Dec 31. Surgery. 2016. PMID: 26747226
-
Predicting morbidity of liver resection.Langenbecks Arch Surg. 2018 May;403(3):359-369. doi: 10.1007/s00423-018-1656-3. Epub 2018 Feb 7. Langenbecks Arch Surg. 2018. PMID: 29417211
-
Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.JAMA Netw Open. 2019 Jan 4;2(1):e186847. doi: 10.1001/jamanetworkopen.2018.6847. JAMA Netw Open. 2019. PMID: 30646202 Free PMC article.
-
Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.HPB (Oxford). 2014 May;16(5):459-68. doi: 10.1111/hpb.12155. Epub 2013 Aug 26. HPB (Oxford). 2014. PMID: 24033514 Free PMC article.
-
Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database.J Surg Res. 2019 Jun;238:35-40. doi: 10.1016/j.jss.2019.01.021. Epub 2019 Feb 5. J Surg Res. 2019. PMID: 30735964
Cited by
-
Coagulopathy after a liver resection: is it over diagnosed and over treated?HPB (Oxford). 2013 Nov;15(11):865-71. doi: 10.1111/hpb.12051. Epub 2013 Jan 29. HPB (Oxford). 2013. PMID: 23458574 Free PMC article. Clinical Trial.
-
Venous Thromboembolism Prophylaxis in Liver Surgery.J Gastrointest Surg. 2016 Jan;20(1):221-9. doi: 10.1007/s11605-015-2902-4. J Gastrointest Surg. 2016. PMID: 26489742
-
Economic burden of cancer among patients with surgical resections of the lung, rectum, liver and uterus: results from a US hospital database claims analysis.Health Econ Rev. 2017 Dec;7(1):22. doi: 10.1186/s13561-017-0160-8. Epub 2017 Jun 2. Health Econ Rev. 2017. PMID: 28577182 Free PMC article.
-
What Is the Current Role and What Are the Prospects of the Robotic Approach in Liver Surgery?Cancers (Basel). 2022 Aug 31;14(17):4268. doi: 10.3390/cancers14174268. Cancers (Basel). 2022. PMID: 36077803 Free PMC article. Review.
-
Predictors of surgical site infection after liver resection: a multicentre analysis using National Surgical Quality Improvement Program data.HPB (Oxford). 2012 Feb;14(2):136-41. doi: 10.1111/j.1477-2574.2011.00417.x. Epub 2011 Dec 13. HPB (Oxford). 2012. PMID: 22221576 Free PMC article.
References
-
- Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Jr., Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg. 2004;199:31–38. - PubMed
-
- Yanaga K, Wakasugi K, Matsusaka T, Kume H. Hepatic resection without mortality at a community hospital. Int Surg. 2003;88:87–91. - PubMed
-
- Morino M, Morra I, Rosso E, Miglietta C, Garrone C. Laparoscopic vs. open hepatic resection: a comparative study. Surg Endosc. 2003;17:1914–1918. - PubMed
-
- Kammula US, Buell JF, Labow DM, Rosen S, Millis JM, Posner MC. Surgical management of benign tumours of the liver. Int J Gastrointest Cancer. 2001;30:141–146. - PubMed
-
- Jacobs M, McDonough J, ReMine SG. Resection of central hepatic malignant lesions. Am Surg. 2003;69:186–189. discussion 189–190. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous